TickerFactsScreenerDevelopers

Spyre Therapeutics, Inc. (SYRE) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2013: -$1.27M2014: -$11.47M2015: -$22.21M2016: $62.97M2017: $50.34M2018: $67.43M2019: $60.08M2020: $139.83M2021: $83.94M2022: $50.30M2023: $184.02M2024: $517.80M2025: $715.24M$715.24M
2013Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$715.24M+38.1%
2024$517.80M+181.4%
2023$184.02M+265.8%
2022$50.30M-40.1%
2021$83.94M-40.0%
2020$139.83M+132.7%
2019$60.08M-10.9%
2018$67.43M+34.0%
2017$50.34M-20.1%
2016$62.97M+383.5%
2015-$22.21M-93.6%
2014-$11.47M-801.3%
2013-$1.27M—